# Triller Group Inc.: overview ILLR · OTC · CIK 1769624 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/illr.md) · [Financials](/companies/illr/financials.md) · [Filings](/companies/illr/filings.md) · [Insiders](/companies/illr/insiders.md) Latest reported revenue: [$5.2m](/filings/0001213900-26-089062.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-089062). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [5,440](/filings/0001213900-26-043228.md) | [9,459 d](/filings/0001213900-26-043341.md) | [4,781](/filings/0001213900-26-055478.md) | [5,515](/filings/0001213900-26-089062.md) | [5,656](/filings/0001213900-26-043228.md) | [5,670 d](/filings/0001213900-26-043341.md) | [5,030](/filings/0001213900-26-055478.md) | [5,226](/filings/0001213900-26-089062.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(166.1%)](/filings/0001213900-26-043228.md) | [(942.2%) d](/filings/0001213900-26-043341.md) | [(924.5%)](/filings/0001213900-26-055478.md) | [(522.8%)](/filings/0001213900-26-089062.md) | [(407.6%)](/filings/0001213900-26-043228.md) | [(746.4%) d](/filings/0001213900-26-043341.md) | [(551.1%)](/filings/0001213900-26-055478.md) | [(432.7%)](/filings/0001213900-26-089062.md) | | Net margin | % | [(173.1%)](/filings/0001213900-26-043228.md) | [(11726.3%) d](/filings/0001213900-26-043341.md) | [(1109.6%)](/filings/0001213900-26-055478.md) | [(584.0%)](/filings/0001213900-26-089062.md) | [(484.0%)](/filings/0001213900-26-043228.md) | [(1091.9%) d](/filings/0001213900-26-043341.md) | [(640.4%)](/filings/0001213900-26-055478.md) | [(542.8%)](/filings/0001213900-26-089062.md) | | Diluted EPS | $ per share | [(0.60)](/filings/0001213900-26-043228.md) | not reported | [(0.32)](/filings/0001213900-26-055478.md) | [(1.79)](/filings/0001213900-26-089062.md) | [(0.18)](/filings/0001213900-26-043228.md) | not reported | [(0.16)](/filings/0001213900-26-055478.md) | [(1.42)](/filings/0001213900-26-089062.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [11.5](/filings/0001213900-23-026399.md) | [31.1](/filings/0001213900-23-026399.md) | [54.2](/filings/0001213900-26-007545.md) | [27.5](/filings/0001213900-26-043341.md) | [21.6](/filings/0001213900-26-043341.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(73.7%)](/filings/0001213900-23-026399.md) | [(91.2%)](/filings/0001213900-24-027225.md) | [(79.5%)](/filings/0001213900-26-007545.md) | [(411.9%)](/filings/0001213900-26-043341.md) | [(640.1%)](/filings/0001213900-26-043341.md) | | Net margin | % | [841.1%](/filings/0001213900-23-026399.md) | [(143.2%)](/filings/0001213900-24-027225.md) | [(90.8%)](/filings/0001213900-26-007545.md) | [(4141.9%)](/filings/0001213900-26-043341.md) | [(807.2%)](/filings/0001213900-26-043341.md) | | Diluted EPS | $ per share | [1.74](/filings/0001213900-23-026399.md) | [(0.79)](/filings/0001213900-24-027225.md) | [(1.56)](/filings/0001213900-26-007545.md) | [(18.08)](/filings/0001213900-26-043341.md) | [(0.97)](/filings/0001213900-26-043341.md) | | Free cash flow | $m | [(2.2)](/filings/0001213900-23-026399.md) | [(20.3)](/filings/0001213900-24-027225.md) | [(42.4)](/filings/0001213900-26-007545.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/illr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Yorkville Advisors Global, LP](/funds/1838613.md) | 2026-06-30 | $1.3m | 480,426 | | New +480,426 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $640.4k | 236,311 | | New +236,311 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $566.3k | 208,981 | | New +208,981 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $417.3k | 153,984 | | New +153,984 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $262.7k | 96,948 | | New +96,948 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $262.5k | 96,874 | | New +96,874 | | [Arax Advisory Partners](/funds/1586767.md) | 2026-06-30 | $226.4k | 83,537 | | New +83,537 | | [Oasis Management Co Ltd.](/funds/1317904.md) | 2026-06-30 | $135.5k | 50,000 | | New +50,000 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $109.5k | 40,392 | | New +40,392 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $98.6k | 36,400 | | New +36,400 | ## Recent filings [All 357 filings](/companies/illr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-02 | 17:00 ET | [8-K](/filings/0001213900-26-096777.md) | 3.01 Delisting notice | 0001213900-26-096777 | | 2026-08-13 | 16:01 ET | [10-Q](/filings/0001213900-26-089062.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089062 | | 2026-08-07 | 17:01 ET | [8-K](/filings/0001213900-26-086776.md) | 3.01 Delisting notice | 0001213900-26-086776 | | 2026-07-15 | 17:00 ET | [8-K](/filings/0001213900-26-078375.md) | 3.01 Delisting notice | 0001213900-26-078375 | | 2026-07-01 | 14:04 ET | [8-K/A](/filings/0001213900-26-074149.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-074149 | | 2026-06-29 | 14:01 ET | [8-K](/filings/0001213900-26-073012.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-073012 | | 2026-06-25 | 08:30 ET | [8-K](/filings/0001213900-26-071784.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-071784 | | 2026-06-24 | 06:01 ET | [8-K](/filings/0001213900-26-071270.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-071270 | | 2026-06-11 | 11:55 ET | [8-K](/filings/0001213900-26-067678.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-067678 | | 2026-06-11 | 11:30 ET | [8-K](/filings/0001213900-26-067658.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-067658 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-043341.md), filed Apr 14, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8c008a36-1826-4b40-813d-931d83b9a522) ## About the filer - CIK: 1769624 - Tickers: ILLR, ILLRW - Exchange: OTC - SIC code: 6282 Investment Advice - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.